Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice

Maria EspositoDepartment of Dermatology, University of Rome ‘Tor Vergata’, Rome, Italy; Correspondence[email protected]

Francesca PrignanoDepartment of Dermatology, University of Florence, Firenze, Italy;

Franco RongiolettiDepartment of Medical Sciences and Public Health, Section of Dermatology, University of Cagliari, Cagliari, Italy;

Katharina HanselDepartment of Medicine, Section of Clinical, Allergological and Venereological Dermatology, University of Perugia, Perugia, Italy;

Leonardo BianchiDepartment of Medicine, Section of Clinical, Allergological and Venereological Dermatology, University of Perugia, Perugia, Italy;

Leonardo PescitelliDepartment of Dermatology, University of Florence, Firenze, Italy;

Linda LazzeriDepartment of Dermatology, University of Florence, Firenze, Italy;

Federica RicceriDepartment of Dermatology, University of Florence, Firenze, Italy;

Cristina MughedduDepartment of Medical Sciences and Public Health, Section of Dermatology, University of Cagliari, Cagliari, Italy;

Mauro BavettaDepartment of Dermatology, University of Rome ‘Tor Vergata’, Rome, Italy;

Arianna ZangrilliDepartment of Dermatology, University of Rome ‘Tor Vergata’, Rome, Italy;

Luca BianchiDepartment of Dermatology, University of Rome ‘Tor Vergata’, Rome, Italy;

Vittorio BiniDepartment of Medicine, Medicine, Endocrine and Metabolic Sciences Section, University of Perugia, Perugia, Italy

Luca StingeniDepartment of Medicine, Section of Clinical, Allergological and Venereological Dermatology, University of Perugia, Perugia, Italy;

Your download is now in progress and you may close this window